suPAR abstract wins 1. prize at DEMC7 Emergency Conference

Thu Dec 01 2016

The abstract “suPAR as a standard prognostic test in the Acute Medical Unit at Hvidovre Hospital”was selected for an oral presentation, and won 1. prize at DEMC7 in Copenhagen, the biggest Emergency Medicine Conference in northern Europe, on November 25.

Line Jee Hartmann Rasmussen from Hvidovre Hospital presented her data  on 17.312 acute medical patients measured with suPAR, to verify the prognostic value of suPAR with regard to readmission and survival.

The conclusion is, that high suPAR was associated with 
– Increased number and severity of comorbidities
– Longer admission time
– High readmission rate– High mortality rate

suPAR remained an independent predictor after adjustment for age, sex, Charlson score, and CRP.

Please find the poster on Lines abstract here

+700

published suPAR studies in leading medical journals

The suPARnostic® brand consists of 3 products:

Photo of The suPARnostic® Quick Triage kit

Quick Triage

A Point of Care Solution

Photo of suPARnostic® TurbiLatex

TurbiLatex

For Automated Systems

Photo of suPARnostic® ELISA

ELISA Assay

Clinical and Research

Would you like to know more?

If you have any questions regarding our products or business, write to us here

Thank you!

You'll hear from us shortly.

An error occured!

Please try again, or contact us by e-mail if the problem persist.

Sign up for our newsletter

By signing up for our newsletter you will receive the latest news about our products.

Thank you!

You'll hear from us shortly.

An error occured!

Please try again, or contact us by e-mail if the problem persist.

New Webinar

Webinar

Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates